We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$377B
AUM Growth
+$49.7B
Cap. Flow
+$31.3B
Cap. Flow %
8.3%
Top 10 Hldgs %
41.14%
Holding
5,593
New
785
Increased
2,954
Reduced
1,009
Closed
322

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Financials 7.13%
3 Consumer Discretionary 6.46%
4 Healthcare 5.43%
5 Communication Services 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
4876
Autolus Therapeutics
AUTL
$389M
$3.6K ﹤0.01%
+993
New +$3.96K
GAU
4877
Galiano Gold
GAU
$457M
$3.55K ﹤0.01%
2,500
FARM
4878
DELISTED
Farmer Brothers
FARM
$3.54K ﹤0.01%
1,786
UDEC
4879
Innovator US Equity Ultra Buffer ETF December
UDEC
$246M
$3.5K ﹤0.01%
+100
New +$3.45K
MCAGU
4880
DELISTED
Mountain Crest Acquisition Corp. V Unit
MCAGU
$3.33K ﹤0.01%
300
YCBD.PRA
4881
DELISTED
cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
$3.17K ﹤0.01%
5,000
DM
4882
DELISTED
Desktop Metal, Inc.
DM
$3.11K ﹤0.01%
666
-38,270
-98% -$176K
BIOR
4883
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$3.02K ﹤0.01%
601
+21
+4% +$136
HCM icon
4884
HUTCHMED
HCM
$1.96B
$2.97K ﹤0.01%
+152
New +$2.75K
LKFT
4885
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$2.88K ﹤0.01%
+100
New +$2.72K
IMVT icon
4886
PUT
Immunovant
IMVT
$7.93B
$2.85K ﹤0.01%
+100
New +$2.95K
TX icon
4887
Ternium
TX
$9.43B
$2.81K ﹤0.01%
76
DVYE icon
4888
iShares Emerging Markets Dividend ETF
DVYE
$1.2B
$2.67K ﹤0.01%
93
KPLT icon
4889
Katapult Holdings
KPLT
$30.3M
$2.65K ﹤0.01%
255
+11
+5% +$161
SEG.RT
4890
DELISTED
Seaport Entertainment Group Inc. Rights (expiring October 10, 2024)
SEG.RT
$2.52K ﹤0.01%
+854
New +$2.46K
LGL icon
4891
LGL Group
LGL
$44.7M
$2.5K ﹤0.01%
408
-988
-71% -$5.62K
IRD
4892
Opus Genetics
IRD
$287M
$2.49K ﹤0.01%
+1,900
New +$2.92K
APT icon
4893
Alpha Pro Tech
APT
$49.9M
$2.43K ﹤0.01%
+426
New +$2.46K
GRIN
4894
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
$2.41K ﹤0.01%
169
-553
-77% -$7.78K
SIL icon
4895
Global X Silver Miners ETF NEW
SIL
$3.93B
$2.39K ﹤0.01%
68
AMTD
4896
AMTD IDEA Group
AMTD
$72.5M
$2.35K ﹤0.01%
1,666
CMRX
4897
DELISTED
Chimerix, Inc.
CMRX
$2.33K ﹤0.01%
2,500
EZA icon
4898
iShares MSCI South Africa ETF
EZA
$534M
$2.27K ﹤0.01%
45
MT icon
4899
ArcelorMittal
MT
$49.5B
$2.26K ﹤0.01%
86
IBO
4900
Impact BioMedical
IBO
$46M
$2.24K ﹤0.01%
+1,120
New +$2.65K

Similar funds

Barclays's Q3 2024 Portfolio in Review

As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.

  • Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
  • Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
  • Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
  • Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
  • Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
  • Barclays opened 785 new positions and closed 322 in Q3 2024.
  • Barclays's portfolio value rose 15% quarter-over-quarter to $377B.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.